The obtained results were in accordance with many other previous findings that COPD airway inflammation can be ameliorated by restraining the expression of TLR4 (Haw et al., 2018), Syk, PKC (Zhang et al., 2018), and p65 (Sun et al., 2019). The gene discussed is TLR4; the disease is chronic obstructive pulmonary disease.